Cerwinka Franz - Mar 1, 2024 Form 4 Insider Report for Xylem Inc. (XYL)

Role
SVP & Pres, AWS & Bus Trnsform
Signature
/s/ Seaneen Cline, by power of attorney for Franz Cerwinka
Stock symbol
XYL
Transactions as of
Mar 1, 2024
Transactions value $
$823,325
Form type
4
Date filed
3/5/2024, 05:01 PM
Previous filing
Feb 12, 2024
Next filing
Oct 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XYL Common Stock Award $154K +1.2K +10.24% $127.94 13K Mar 1, 2024 Direct F1
transaction XYL Common Stock Award $250K +1.96K +15.1% $127.94 14.9K Mar 1, 2024 Direct F2
transaction XYL Common Stock Tax liability -$193K -1.51K -10.12% $127.94 13.4K Mar 1, 2024 Direct F3
transaction XYL Common Stock Tax liability -$93.4K -730 -5.45% $127.94 12.7K Mar 1, 2024 Direct F4
transaction XYL Common Stock Award $200K +1.56K +12.34% $127.94 14.2K Mar 1, 2024 Direct F5
transaction XYL Common Stock Sale -$171K -1.34K -9.42% $127.44 12.9K Mar 1, 2024 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XYL Stock Options (Right to buy) Award $677K +5.29K $127.94 5.29K Mar 1, 2024 Common Stock 5.29K $127.94 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the acquisition of 1,203 shares of common stock upon vesting of performance-based restricted stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
F2 Reflects the acquisition of 1,956 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC.
F3 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
F4 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (193), March 1, 2022 (246), and March 1, 2023 (291) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
F5 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027.
F6 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a price of $127.44. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F7 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027.